The global market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Antibody Drug Conjugates Contract Manufacturing players cover Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Antibody Drug Conjugates Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Antibody Drug Conjugates Contract Manufacturing market, with both quantitative and qualitative data, to help readers understand how the Antibody Drug Conjugates Contract Manufacturing market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:

The study segments the Antibody Drug Conjugates Contract Manufacturing market and forecasts the market size by Type (IgG1, IgG2 and IgG4), by Application (Solid Tumors and Hematological Malignancies.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type

IgG1

IgG2

IgG4

Segmentation by application

Solid Tumors

Hematological Malignancies

Segmentation by region

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Major companies covered

Lonza Group

Piramal Pharma Solutions

Abbvie

Novasep

Merck

Cambrex Corporation

Recipharm

Thermo Fisher Scientific

Cerbios-Pharma

Sterling Pharma Solutions

ADC Biotechnology

Ajinomoto Bio-Pharma Services

BOC Sciences

BSP Pharmaceuticals

CARBOGEN AMCIS

Goodwin Biotechnology

Chapter Introduction

Chapter 1: Scope of Antibody Drug Conjugates Contract Manufacturing, Research Methodology, etc.

Chapter 2: Executive Summary, global Antibody Drug Conjugates Contract Manufacturing market size and CAGR, Antibody Drug Conjugates Contract Manufacturing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Antibody Drug Conjugates Contract Manufacturing revenue, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Antibody Drug Conjugates Contract Manufacturing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Antibody Drug Conjugates Contract Manufacturing market size forecast by region, by country, by type, and application

Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep, Merck, Cambrex Corporation, Recipharm, Thermo Fisher Scientific and Cerbios-Pharma, etc.

Chapter 14: Research Findings and Conclusion